Relevant bibliographies by topics / Biomarker panels

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Biomarker panels'

Author: Grafiati
Published: 3 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Biomarker panels.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Biomarker panels"

1

Berben, Lieze, Asier Antoranz, Cindy Kenis, et al. "Blood Immunosenescence Signatures Reflecting Age, Frailty and Tumor Immune Infiltrate in Patients with Early Luminal Breast Cancer." Cancers 13, no. 9 (2021): 2185. http://dx.doi.org/10.3390/cancers13092185.

Full text
Abstract:
Background: Immune/senescence-related host factors play a pivotal role in numerous biological and pathological process like aging, frailty and cancer. The assessment of these host factors via robust, non-invasive, and easy-to-measure blood biomarkers could improve insights in these processes. Here, we investigated in a series of breast cancer patients in which way single circulating biomarkers or biomarker panels relate to chronological age, frailty status, and tumor-associated inflammatory microenvironment. Methods: An extensive panel of blood immune/senescence markers and the tumor immune in
APA, Harvard, Vancouver, ISO, and other styles
2

Stoker, Aaron, Emily Leary, Chantelle Bozynski, James Stannard, James Cook, and Michael Ewing. "Paper 33: Serum and Urine Biomarkers for Treatment Monitoring after Meniscal Allograft Transplantation in a Preclinical Canine Model." Orthopaedic Journal of Sports Medicine 10, no. 7_suppl5 (2022): 2325967121S0059. http://dx.doi.org/10.1177/2325967121s00597.

Full text
Abstract:
Objectives: To analyze serum and urine biomarker concentrations for their capabilities in delineating differences in assessments of pain and functional outcomes after meniscus allograft transplantation (MAT) in a preclinical canine model. The study was designed to test the hypothesis that serum and urine biomarkers could be used for prognostic (1- and 3-month post-surgical time points) and diagnostic (6-month time point) assessments, based on strong associations with clinically relevant pain and function outcomes after MAT. Methods: Twelve adult, purpose-bred research hounds were included and
APA, Harvard, Vancouver, ISO, and other styles
3

Cho, Hyung Joon, Philip Schulz, Lalitha Venkataraman, Richard J. Caselli, and Michael R. Sierks. "Sex-Specific Multiparameter Blood Test for the Early Diagnosis of Alzheimer’s Disease." International Journal of Molecular Sciences 23, no. 24 (2022): 15670. http://dx.doi.org/10.3390/ijms232415670.

Full text
Abstract:
Blood-based biomarkers are needed for the early diagnosis of Alzheimer’s disease (AD). We analyzed longitudinal human plasma samples from AD and control cases to identify biomarkers for the early diagnosis of AD. Plasma samples were grouped based on clinical diagnosis at the time of collection: AD, mild cognitive impairment (MCI), and pre-symptomatic (preMCI). Samples were analyzed by ELISA using a panel of reagents against nine different AD-related amyloid-β (Aβ), tau, or TDP-43 variants. Receiver operating characteristic (ROC) curves of different biomarker panels for different diagnostic sam
APA, Harvard, Vancouver, ISO, and other styles
4

Sprague, Alexander C., Damaris Kuhnell, Wei-Wen Hsu, Trisha Wise-Draper, and Scott Langevin. "Abstract B051: Elastic net discovery of DNA methylation biomarkers for non-invasive diagnosis and recurrence detection in head and neck cancer." Clinical Cancer Research 31, no. 13_Supplement (2025): B051. https://doi.org/10.1158/1557-3265.aimachine-b051.

Full text
Abstract:
Abstract Background: Head and neck squamous cell carcinoma (HNSCC) is diagnosed in nearly 60,000 Americans each year. Despite therapeutic advances in recent decades, survival rates have remained largely unchanged. A major contributing factor to poor outcomes is the lack of a non-invasive screening test for HNSCC, as well as the high recurrence rates within two years of curative therapy. In this study, we aimed to leverage elastic net penalized regression to identify and validate DNA methylation biomarkers for HNSCC using non-invasive oral rinse samples. Methods: Oral rinse methylation data fro
APA, Harvard, Vancouver, ISO, and other styles
5

Onoja, Anthony, Johanna von Gerichten, Holly-May Lewis, et al. "Meta-Analysis of COVID-19 Metabolomics Identifies Variations in Robustness of Biomarkers." International Journal of Molecular Sciences 24, no. 18 (2023): 14371. http://dx.doi.org/10.3390/ijms241814371.

Full text
Abstract:
The global COVID-19 pandemic resulted in widespread harms but also rapid advances in vaccine development, diagnostic testing, and treatment. As the disease moves to endemic status, the need to identify characteristic biomarkers of the disease for diagnostics or therapeutics has lessened, but lessons can still be learned to inform biomarker research in dealing with future pathogens. In this work, we test five sets of research-derived biomarkers against an independent targeted and quantitative Liquid Chromatography–Mass Spectrometry metabolomics dataset to evaluate how robustly these proposed pa
APA, Harvard, Vancouver, ISO, and other styles
6

Peng, Hong, Sheng Pan, Yuanqing Yan, et al. "Systemic Proteome Alterations Linked to Early Stage Pancreatic Cancer in Diabetic Patients." Cancers 12, no. 6 (2020): 1534. http://dx.doi.org/10.3390/cancers12061534.

Full text
Abstract:
Background: Diabetes is a risk factor associated with pancreatic ductal adenocarcinoma (PDAC), and new adult-onset diabetes can be an early sign of pancreatic malignancy. Development of blood-based biomarkers to identify diabetic patients who warrant imaging tests for cancer detection may represent a realistic approach to facilitate earlier diagnosis of PDAC in a risk population. Methods: A spectral library-based proteomic platform was applied to interrogate biomarker candidates in plasma samples from clinically well-defined diabetic cohorts with and without PDAC. Random forest algorithm was u
APA, Harvard, Vancouver, ISO, and other styles
7

Jickling, Glen C., and Frank R. Sharp. "Biomarker Panels in Ischemic Stroke." Stroke 46, no. 3 (2015): 915–20. http://dx.doi.org/10.1161/strokeaha.114.005604.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Conway, Susan R., and Hector R. Wong. "Biomarker Panels in Critical Care." Critical Care Clinics 36, no. 1 (2020): 89–104. http://dx.doi.org/10.1016/j.ccc.2019.08.007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Fox, John Leonard, Sugganth Daniel, and Manavi Abrol. "NGS panels' capture of biomarkers associated with targeted therapies in clinical trials." Journal of Clinical Oncology 42, no. 16_suppl (2024): e13508-e13508. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.e13508.

Full text
Abstract:
e13508 Background: ASCO and NCCN guidelines strongly encourage participation in clinical trials though participation rates remain low. Although up to 60% of trials require biomarker information as a prerequisite to participation, guidelines are silent on biomarker testing to assess eligibility. To help inform policy development, we analyzed commercially available NGS panels to assess the capture rate of the specific gene variants required for targeted therapies in clinical trials. Methods: Publicly available gene variant information on 12 high volume NGS tissue and plasma commercial assays rep
APA, Harvard, Vancouver, ISO, and other styles
10

Higginbotham, Lenora, Lingyan Ping, Eric B. Dammer, et al. "Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease." Science Advances 6, no. 43 (2020): eaaz9360. http://dx.doi.org/10.1126/sciadv.aaz9360.

Full text
Abstract:
Alzheimer’s disease (AD) lacks protein biomarkers reflective of its diverse underlying pathophysiology, hindering diagnostic and therapeutic advancements. Here, we used integrative proteomics to identify cerebrospinal fluid (CSF) biomarkers representing a wide spectrum of AD pathophysiology. Multiplex mass spectrometry identified ~3500 and ~12,000 proteins in AD CSF and brain, respectively. Network analysis of the brain proteome resolved 44 biologically diverse modules, 15 of which overlapped with the CSF proteome. CSF AD markers in these overlapping modules were collapsed into five protein pa
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Biomarker panels"

1

Singh, Amritpal. "Blood biomarker panels of the late phase asthmatic response." Thesis, University of British Columbia, 2016. http://hdl.handle.net/2429/58777.

Full text
Abstract:
The full abstract for this thesis is available in the body of the thesis, and will be available when the embargo expires.<br>Medicine, Faculty of<br>Experimental Medicine, Division of<br>Medicine, Department of<br>Graduate
APA, Harvard, Vancouver, ISO, and other styles
2

Hupf, Julian Johannes Magnus [Verfasser], and Carsten [Akademischer Betreuer] Jungbauer. "Evaluation eines innovativen Biomarker-Panels bei Patienten mit akutem Brustschmerz / Julian Johannes Magnus Hupf ; Betreuer: Carsten Jungbauer." Regensburg : Universitätsbibliothek Regensburg, 2019. http://d-nb.info/1176808761/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Pujade, Laura. "Development of a biomarker panel for identifying stressed marine mammals." Scholarly Commons, 2019. https://scholarlycommons.pacific.edu/uop_etds/3587.

Full text
Abstract:
Increasing anthropogenic disturbance in marine ecosystems such as fishing, oil-drilling, and noise pollution can have detrimental effects on the reproduction and survival of apex predators such as marine mammals. Stress activates the hypothalamic-pituitary-adrenal (HPA) axis, resulting in increased circulating glucocorticoid (GCs) hormones, which alter expression of target genes encoding metabolic enzymes and other mediators of stress. Prolonged HPA axis stimulation may increase catabolism of nutrient stores and suppress immune and reproductive functions, impacting the fitness of marine mammal
APA, Harvard, Vancouver, ISO, and other styles
4

Zhang, Xi. "The development and validation of a salivary protein panel to diagnose heart failure." Thesis, Queensland University of Technology, 2018. https://eprints.qut.edu.au/122851/2/Xi_Zhang_Thesis.pdf.

Full text
Abstract:
Heart failure (HF) is a severe complication that affects 26 million people world-wide the lack of early screening programs in HF hinders early detection and targeted treatment and hence contributes greatly to the deaths associated with HF. By using human saliva as an alternative medium, a multi-protein biomarker panel were discovered using Sequential Window Acquisition of All Theoretical fragment ion spectra – Mass Spectrometry (SWATHMS). This panel was further validated and demonstrated excellent diagnostic performance with an overall accuracy of 84%. The finding in this thesis has the potent
APA, Harvard, Vancouver, ISO, and other styles
5

Smith, Eve Mary Dorothy. "Developing a lupus nephritis urinary biomarker panel in children for use in a clinical trial." Thesis, University of Liverpool, 2016. http://livrepository.liverpool.ac.uk/3003957/.

Full text
Abstract:
Background: Juvenile-onset systemic lupus erythematosus (JSLE) is a rare, severe multisystem autoimmune disease affecting the kidney (Lupus Nephritis, LN) in up to 80% of children. Numerous individual urinary biomarkers have previously been investigated. No individual biomarker has achieved ‘excellence’ in differentiating active from inactive LN. Aims: (1) To assess performance of traditional clinical biomarkers for LN monitoring and prediction of LN outcomes. (2) To select biomarkers warranting assessment in a ‘LN biomarker panel’; to cross-sectionally assess if combining novel/traditional bi
APA, Harvard, Vancouver, ISO, and other styles
6

Qureshi, Ayesha. "Assessment of a novel biomarker panel for the earlier prediction of acute kidney injury in patients with diabetes mellitus undergoing coronary angiography and intervention." Thesis, Queen Mary, University of London, 2012. http://qmro.qmul.ac.uk/xmlui/handle/123456789/2530.

Full text
Abstract:
Diabetes mellitus triples the risk of developing coronary heart disease (CHD). The manifestations of CHD are more severe in patients with diabetes with both more extensive and more diffuse disease. Outcomes in patients with diabetes are significantly worse both in terms of Major Adverse Cardiovascular Events (MACE) overall and specifically following revascularisation procedures such as percutaneous coronary intervention (PCI). Furthermore patients with chronic kidney disease (CKD) are excluded from the vast majority of cardiology trials and therefore there is a lack of data for these patients.
APA, Harvard, Vancouver, ISO, and other styles
7

Pechańska, Paulina [Verfasser], Peter-Michael Akademischer Betreuer] Kloetzel, Uwe [Akademischer Betreuer] Ohler, and André [Akademischer Betreuer] [Rosenthal. "A novel approach to develop predictive biomarkers : prediction of response to anti-EGFR therapy in a large panel of patient-derived colorectal cancer xenograft models / Paulina Pechanska. Gutachter: Peter-Michael Kloetzel ; Uwe Ohler ; André Rosenthal." Berlin : Humboldt Universität zu Berlin, Mathematisch-Naturwissenschaftliche Fakultät I, 2014. http://d-nb.info/1051848350/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Beaudoux, Olivia. "Caractérisation anatomo-clinique et moléculaire du mélanome primitif muqueux Prognostic factors and incidence of primary mucosal melanoma: a population-based study in France Massively invasive orbital melanoma: Uveal or conjunctival origin? “Response to imatinib of a patient with double-mutant KIT metastatic penile melanoma." Thesis, Reims, 2020. http://www.theses.fr/2020REIMM201.

Full text
Abstract:
Le mélanome (M) primitif muqueux (MM) est une tumeur maligne rare et grave, comprenant les M buccaux et nasopharyngés, vulvovaginaux, conjonctivaux, anorectaux et péniens (MP). Les oncogènes impliqués sont largement inconnus. Les cas non résécables et métastatiques sont peu sensibles aux traitements actuels, thérapies ciblées et immunothérapies. Afin de mieux caractériser ces cancers orphelins, nous avons: (1) étudié, sur la base des cas incidents de Champagne-Ardenne entre 2004 et 2014 (n=39), l'incidence annuelle (0,18/100000) et le ratio d'incidence MM/M cutané (1/50), la fréquence relative
APA, Harvard, Vancouver, ISO, and other styles
9

Jäger, Jochen [Verfasser]. "Deriving small diagnostic biomarker panels from genome wide, clinical microarray studies / Jochen Jäger." 2006. http://d-nb.info/981806643/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Martin, Karina. "Utilising quantitative immunoproteomics to reveal differential autoantibody biomarker panels in serous ovarian cancer patients." Thesis, 2015. http://hdl.handle.net/2440/98148.

Full text
Abstract:
Epithelial ovarian cancer accounts for 5% of all cancer deaths and greater than 50% of all gynaecological cancer deaths. It presents at a late clinical stage in more than 60% of patients, and is associated with a 5-year survival of only 30% in this group. In contrast, the 5-year survival for patients with organ-confined stage I ovarian cancer exceeds 90%, and most patients are cured of their disease. Thus, the detection of early stage ovarian cancer is the best way to improve survival. No clinically applicable method exists for the early detection of ovarian cancer. Hence, there is an unmet me
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Biomarker panels"

1

Kochanek, Patrick M., and Rachel P. Berger. Brain injury biomarkers in the critically ill. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0300.

Full text
Abstract:
A variety of biomarkers of brain injury are being developed in neurocritical care to study secondary injury pathways or aid in diagnostic, prognostic, and/or theragnostic applications. This chapter focuses largely on brain injury biomarkers that can be detected in serum or cerebrospinal fluid samples from patients with acute critical brain injury of various causes. Much of the work has been carried using biomarkers of proteins that are relatively unique to the brain, and that reflect damage to important cellular constituents such as neurons, astroycytes, or axons. Novel approaches that employ
APA, Harvard, Vancouver, ISO, and other styles
2

Huang, David T., and Ayan Sen. Novel biomarkers of infection in the critically ill. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0282.

Full text
Abstract:
Over 25% of all annual deaths in the world are due to infection. Early diagnosis and risk stratification facilitate timely and specific treatment, but are complicated by the highly variable and non-specific nature of the signs and symptoms of sepsis. There is a lack of a ‘gold standard’ for the diagnosis of infection or sepsis, prognosis of severe infections, and sepsis. There are several biomarkers that have been investigated in literature like white blood count, C-reactive protein, procalcitonin, sTREM1, etc., with equivocal results. White blood count and C-reactive protein are elevated in s
APA, Harvard, Vancouver, ISO, and other styles
3

Grazioli, Erica, Channa Kolb, and Bianca Weinstock-Guttman. Temporal and Clinical Course of Multiple Sclerosis. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199341016.003.0010.

Full text
Abstract:
The temporal and clinical course of multiple sclerosis is heterogeneous, varying among patients as well as over time in the same individual. Greater specificity in describing disease classification and course is important for conduct of clinical trials as well as prognosis for individual patients. This chapter reviews the results of recent consensus panels that have further defined the relapsing and progressive forms of multiple sclerosis through clarification of clinical relapse, subclinical relapse, active disease, and progressive disease. Clinical characteristics, conventional and nonconven
APA, Harvard, Vancouver, ISO, and other styles
4

Walsh, Richard A. Siblings with Instability. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190607555.003.0015.

Full text
Abstract:
Over the past 5 years, there has been a shift in the approach to searching for a genetic diagnosis in familial ataxic syndromes. Whereas in the past, a limited but expensive search through a selection of commercially available genes using Sanger sequencing was performed, there is now widespread availability of gene panels utilizing next-generation sequencing techniques. This is an efficient and powerful approach that may achieve a diagnosis in more than 30% of patients with a familial ataxia that remain undiagnosed. However, accurate phenotyping remains critical to allow interpretation of sequ
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Biomarker panels"

1

Jebsen, Nina Louise, Samantha Scarlett, Bergrun Tinna Magnusdottir, and Bjørn Tore Gjertsen. "Biomarker Panels and Contemporary Practice in Clinical Trials of Targeted Therapy." In Biomarkers of the Tumor Microenvironment. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-39147-2_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Jebsen, Nina Louise, Irini Ktoridou-Valen, and Bjørn Tore Gjertsen. "Biomarker Panels and Contemporary Practice in Clinical Trials of Personalized Medicine." In Biomarkers of the Tumor Microenvironment. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-98950-7_33.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Spratt, Heidi M., and Hyunsu Ju. "Statistical Approaches to Candidate Biomarker Panel Selection." In Modern Proteomics – Sample Preparation, Analysis and Practical Applications. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-41448-5_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Jerban, Saeed, Yajun Ma, Eric Y. Chang, Christine B. Chung, Graeme M. Bydder, and Jiang Du. "A UTE-Based Biomarker Panel in Osteoporosis." In MRI of Short and Ultrashort-T_2 Tissues. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-35197-6_34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Heinzel, Andreas, Irmgard Mühlberger, Raul Fechete, Bernd Mayer, and Paul Perco. "Functional Molecular Units for Guiding Biomarker Panel Design." In Methods in Molecular Biology. Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-0709-0_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Floares, Alexandru George, Irina Luludachi, Colin Dinney, and Liana Adam. "Boosted C5 Trees i-Biomarkers Panel for Invasive Bladder Cancer Progression Prediction." In Computational Intelligence Methods for Bioinformatics and Biostatistics. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-35686-5_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Brossollet, Ivan, Quentin Gallet, Pauline Favre, and Josselin Houenou. "Machine Learning and Brain Imaging for Psychiatric Disorders: New Perspectives." In Machine Learning for Brain Disorders. Springer US, 2023. http://dx.doi.org/10.1007/978-1-0716-3195-9_32.

Full text
Abstract:
AbstractPsychiatric disorders include a broad panel of heterogeneous conditions. Among the most severe psychiatric diseases, in intensity and incidence, depression will affect 15–20% of the population in their lifetime, schizophrenia 0.7–1%, and bipolar disorder 1–2.5%. Today, the diagnosis is solely based on clinical evaluation, causing major issues since it is subjective and as different diseases can present similar symptoms. These limitations in diagnosis lead to limitations in the classification of psychiatric diseases and treatments. There is therefore a great need for new biomarkers, usa
APA, Harvard, Vancouver, ISO, and other styles
8

Percy, Andrew J., and Christoph H. Borchers. "Detailed Method for Performing the ExSTA Approach in Quantitative Bottom-Up Plasma." In Methods in Molecular Biology. Springer US, 2021. http://dx.doi.org/10.1007/978-1-0716-1024-4_25.

Full text
Abstract:
AbstractThe use of stable isotope-labeled standards (SIS) is an analytically valid means of quantifying proteins in biological samples. The nature of the labeled standards and their point of insertion in a bottom-up proteomic workflow can vary, with quantification methods utilizing curves in analytically sound practices. A promising quantification strategy for low sample amounts is external standard addition (ExSTA). In ExSTA, multipoint calibration curves are generated in buffer using serially diluted natural (NAT) peptides and a fixed concentration of SIS peptides. Equal concentrations of SI
APA, Harvard, Vancouver, ISO, and other styles
9

Matveeva, Tatiana, and Gita Amini. "Fluidigm BioMark Diagnostic Panel for Analysis of the Expression of Nicotiana tabacum Genes, Associated with Alkaloid Synthesis." In Hairy Root Cultures Based Applications. Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-4055-4_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Padoan, Andrea, Daniela Bernardi, and Mario Plebani. "Biomarker Panels and Multiple Readouts." In Principles of Translational Science in Medicine. Elsevier, 2015. http://dx.doi.org/10.1016/b978-0-12-800687-0.00017-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Biomarker panels"

1

Rubino, Franco, Christopher Alvarez-Breckenridge, Kadir Akdemir, et al. "Prognostic Molecular Biomarkers in Chordomas: A Systematic Review and Identification of Clinically Usable Biomarker Panels." In 32nd Annual Meeting North American Skull Base Society. Georg Thieme Verlag KG, 2023. http://dx.doi.org/10.1055/s-0043-1762258.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Schmalle, Victor, Julia Renz, Stephanie Seifert, et al. "Dietary Assessment of Plant Food Intake Using Multi-Biomarker Panels." In European Nutrition Conference. MDPI, 2024. http://dx.doi.org/10.3390/proceedings2023091253.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Elhalwagy, Mohamed, Bernardo Lopes, Anthony Evans, Ahmed Elsheikh, and Philip Johnson. "O50 Multi-biomarker panels for the identification of hepatocellular carcinoma." In Abstracts of the BSG Annual Meeting, BSG LIVE’25, 23–26 June 2025, SEC Glasgow. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2025. https://doi.org/10.1136/gutjnl-2025-bsg.50.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Rucevic, Marijana, Arnav Mehta, Katarina Horneaus, et al. "152 Immuno-oncology protein biomarker panels provide greater biological insights and improved patient stratification." In SITC 38th Annual Meeting (SITC 2023) Abstracts. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/jitc-2023-sitc2023.0152.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Henderson, MC, T.-F. Yeh, DE Reese, S. Borman, and A. Hollingsworth. "Abstract P6-05-20: Designing biomarker panels for pre- and post-menopausal breast cancer diagnostic testing using MSD technology." In Abstracts: Thirty-Sixth Annual CTRC-AACR San Antonio Breast Cancer Symposium - Dec 10-14, 2013; San Antonio, TX. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/0008-5472.sabcs13-p6-05-20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sim, C., J. Steele, H. C. Lee, et al. "Bronchoalveolar Lavage Fluid Proteome Profiling of Victorian Engineered-stone Workers with Silicosis Reveals Novel Disease Processes and Identifies Potential Biomarker Panels." In American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CA. American Thoracic Society, 2024. http://dx.doi.org/10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a3050.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Cairo, Stefano, Olivier Déas, Marie-Emmanuelle Legrier-Rahali, et al. "Abstract 5273: XenTech patient-derived xenograft (PDX) panels: a clinically relevant platform for drug efficacy, target validation and predictive biomarker discovery studies." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-5273.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Schaefer, Rachel, Jacob Circelli, Oscar Perez, Linying Liu, Michael McLane, and Yi Zheng. "160 Novel, high-plex, and flexible biomarker panels for rapid development of spatial signatures to improve stratification of response to combination therapies." In SITC 37th Annual Meeting (SITC 2022) Abstracts. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/jitc-2022-sitc2022.0160.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Chenchik, Alex, Paul Diehl, Leonid Iakoubov, and Costa Frangou. "Abstract A23: CancerNet biomarker profiling panel." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; November 5-9, 2015; Boston, MA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1535-7163.targ-15-a23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Johnson, David, Brandon Shafer, Jaehwan John Lee, and Jake Y. Chen. "Multi-biomarker panel selection on a GPU." In 2012 IEEE International Conference on Electro/Information Technology (EIT 2012). IEEE, 2012. http://dx.doi.org/10.1109/eit.2012.6220762.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Biomarker panels"

1

Steele, Lea. Biomarker Discovery in Gulf War Veterans: Development of a War Illness Diagnostic Panel. Defense Technical Information Center, 2014. http://dx.doi.org/10.21236/ada614247.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Steele, Lea. Biomarker Discovery in Gulf War Veterans: Development of a War Illness Diagnostic Panel. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada596554.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kulkarni, Prakash. A Multiplex Cancer/Testis Antigen-Based Biomarker Panel to Predict the Aggressive Phenotype of Prostate Cancer. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada590492.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Cotti, Chad, Philip DeCicca, and Erik Nesson. The Effects of Tobacco 21 Laws on Smoking and Vaping: Evidence from Panel Data and Biomarkers. National Bureau of Economic Research, 2024. http://dx.doi.org/10.3386/w32520.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Peterson, Bradley S., Joey Trampush, Margaret Maglione, et al. ADHD Diagnosis and Treatment in Children and Adolescents. Agency for Healthcare Research and Quality (AHRQ), 2024. http://dx.doi.org/10.23970/ahrqepccer267.

Full text
Abstract:
Objective. The systematic review assessed evidence on the diagnosis, treatment, and monitoring of attention deficit hyperactivity disorder (ADHD) in children and adolescents to inform a planned update of the American Academy of Pediatrics (AAP) guidelines. Data sources. We searched PubMed®, Embase®, PsycINFO®, ERIC, clinicaltrials.gov, and prior reviews for primary studies published since 1980. The report includes studies published to June 15, 2023. Review methods. The review followed a detailed protocol and was supported by a Technical Expert Panel. Citation screening was facilitated by machi
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Biomarker panels' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography